Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Regentis Biomaterials total assets
Total assets on the balance sheet at the end of each period.
Regentis Biomaterials's total assets was $9.35M at Jun 30, 2026. For fiscal 2025 it was $7.62M, up 1480.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.62M | +1480.5% |
| FY2024 | Dec 31, 2024 | $482.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.35M | – |
| Q4 FY2025 | Dec 31, 2025 | $7.62M | – |
| Q4 FY2024 | Dec 31, 2024 | $482.00K | – |
See a number that looks wrong?